• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20 年来英格兰和威尔士通过注射吸毒控制艾滋病毒传播的成败,1990 年至 2011 年。

Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011.

机构信息

Centre for Infectious Disease Surveillance and Control, Public Health England, London, United Kingdom.

出版信息

Euro Surveill. 2014 Apr 10;19(14):20762. doi: 10.2807/1560-7917.es2014.19.14.20762.

DOI:10.2807/1560-7917.es2014.19.14.20762
PMID:24739984
Abstract

Responses to injecting drug use have changed focus over the last 20 years. Prevalence and incidence of human immunodeficiency virus (HIV) among people who inject drugs (PWID) in England and Wales were examined in relation to these changes. A voluntary unlinked-anonymous surveillance study obtained a biological sample and questionnaire data from PWID through annual surveys since 1990. Prevalence and incidence trends were estimated via generalised linear models, and compared with a policy time-line. Overall HIV prevalence among 38,539 participations was 1.15%. Prevalence was highest among those who started injecting before 1985; throughout the 1990s, prevalence fell in this group and was stable among those who started injecting later. Prevalence was higher in 2005 than 2000 (odds ratio: 3.56 (95% confidence interval (CI) 1.40–9.03) in London, 3.40 (95% CI 2.31–5.02) elsewhere). Estimated HIV incidence peaked twice, around 1983 and 2005. HIV was an important focus of policy concerning PWID from 1984 until 1998. This focus shifted at a time when drug use and risk were changing. The increased incidence in 2005 cannot be ascribed to the policy changes, but these appeared to be temporally aligned. Policy related to PWID should be continually reviewed to ensure rapid responses to increased risk.

摘要

过去 20 年来,针对吸毒的应对措施已经发生了变化。本研究旨在调查英格兰和威尔士注射吸毒者(PWID)中人类免疫缺陷病毒(HIV)的流行率和发病率与这些变化的关系。自 1990 年以来,通过年度调查,我们对参加者进行了一项自愿的、不相关的匿名监测研究,收集了他们的生物样本和问卷调查数据。通过广义线性模型估计了流行率和发病率趋势,并与政策时间线进行了比较。在 38539 名参加者中,HIV 的总体流行率为 1.15%。在开始吸毒时间早于 1985 年的人群中,流行率最高;在整个 1990 年代,该人群的流行率下降,而开始吸毒时间较晚的人群则保持稳定。与 2000 年相比,2005 年的流行率更高(在伦敦,比值比为 3.56(95%置信区间(CI)为 1.40-9.03),在其他地方为 3.40(95% CI 为 2.31-5.02))。HIV 估计发病率在 1983 年和 2005 年两次达到峰值。从 1984 年到 1998 年,HIV 一直是针对 PWID 政策的重要关注点。在吸毒和风险发生变化的同时,这一重点也发生了转移。2005 年发病率的增加不能归因于政策变化,但这些变化似乎是同时发生的。针对 PWID 的政策应定期进行审查,以确保对风险增加做出快速反应。

相似文献

1
Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011.20 年来英格兰和威尔士通过注射吸毒控制艾滋病毒传播的成败,1990 年至 2011 年。
Euro Surveill. 2014 Apr 10;19(14):20762. doi: 10.2807/1560-7917.es2014.19.14.20762.
2
HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years.1990年至2003年英格兰和威尔士注射吸毒者中的艾滋病毒流行情况:近年来传播增加的证据。
AIDS. 2005 Jul 22;19(11):1207-14. doi: 10.1097/01.aids.0000176222.71355.a1.
3
An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.坦桑尼亚急需扩大注射毒品危害减少服务规模:2011 年达累斯萨拉姆坦盖雷区吸毒者中血源性病毒流行情况。
Int J Drug Policy. 2013 Jan;24(1):78-81. doi: 10.1016/j.drugpo.2012.08.005. Epub 2012 Oct 1.
4
HIV infection in injecting drug users attending centres in England and Wales, 1990-1991.1990 - 1991年,在英格兰和威尔士的注射吸毒者治疗中心的艾滋病毒感染情况。
AIDS. 1993 Nov;7(11):1501-7. doi: 10.1097/00002030-199311000-00015.
5
Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again?英格兰和威尔士注射吸毒者中的丙型肝炎感染情况(1992 - 2006年):来来回回?
Am J Epidemiol. 2009 Aug 1;170(3):352-60. doi: 10.1093/aje/kwp141. Epub 2009 Jun 22.
6
Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.调查英格兰、威尔士和北爱尔兰注射吸毒者中与丙型肝炎病毒检测相关的社会人口学和行为因素:一项定量横断面分析。
Int J Drug Policy. 2022 Nov;109:103821. doi: 10.1016/j.drugpo.2022.103821. Epub 2022 Aug 20.
7
Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92.1990 - 1992年英格兰和威尔士未关联匿名艾滋病毒流行情况监测
Commun Dis Rep CDR Rev. 1993 Jan 1;3(1):R1-11.
8
Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.1992 - 2013年英格兰和威尔士注射形象与性能增强药物男性人群中随时间推移感染艾滋病毒、乙型肝炎和丙型肝炎的风险:横断面患病率调查结果
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):331-7. doi: 10.1097/QAI.0000000000000835.
9
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.注射吸毒者中艾滋病毒、乙肝表面抗原和丙型肝炎抗体阳性的高流行率:莫桑比克两个城市地区首次采用应答者驱动抽样进行生物行为调查的结果。
BMC Infect Dis. 2019 Dec 2;19(1):1022. doi: 10.1186/s12879-019-4655-2.
10
Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.尽管存在全面的减少伤害环境,但与注射吸毒相关的 HIV 再次出现:一项横断面分析。
Lancet HIV. 2019 May;6(5):e315-e324. doi: 10.1016/S2352-3018(19)30036-0. Epub 2019 Apr 10.

引用本文的文献

1
Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on.英格兰、威尔士和北爱尔兰注射吸毒人群中 HIV 感染及相关行为的流行病学:近 40 年的研究。
HIV Med. 2022 Oct;23(9):978-989. doi: 10.1111/hiv.13297. Epub 2022 Mar 30.
2
HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.HIV 血清流行率在欧洲五个重点人群中的研究:系统文献回顾,2009 年至 2019 年。
Euro Surveill. 2021 Nov;26(47). doi: 10.2807/1560-7917.ES.2021.26.47.2100044.
3
The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.
英格兰注射吸毒人群中直接作用抗病毒药物对丙型肝炎病毒血症的影响;2011-2018 年真实世界数据。
J Viral Hepat. 2021 Oct;28(10):1452-1463. doi: 10.1111/jvh.13575. Epub 2021 Jul 29.
4
A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.两种丙型肝炎病毒(HCV)近期感染生物标志物的比较:对监测干预措施和减少注射吸毒人群 HCV 传播策略的影响。
Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1700635.
5
Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.1992 - 2013年英格兰和威尔士注射形象与性能增强药物男性人群中随时间推移感染艾滋病毒、乙型肝炎和丙型肝炎的风险:横断面患病率调查结果
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):331-7. doi: 10.1097/QAI.0000000000000835.